ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 72 filers reported holding ATHIRA PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,671 | -41.5% | 9,738 | -14.6% | 0.00% | -50.0% |
| Q2 2023 | $33,651 | +18.0% | 11,407 | 0.0% | 0.00% | +33.3% |
| Q1 2023 | $28,518 | -21.1% | 11,407 | 0.0% | 0.00% | -25.0% |
| Q4 2022 | $36,160 | -27.7% | 11,407 | -32.6% | 0.00% | -50.0% |
| Q3 2022 | $50,000 | -29.6% | 16,920 | -27.8% | 0.01% | -33.3% |
| Q2 2022 | $71,000 | -78.2% | 23,420 | -3.1% | 0.01% | -76.0% |
| Q1 2022 | $326,000 | +7.6% | 24,173 | +4.1% | 0.05% | +8.7% |
| Q4 2021 | $303,000 | +114.9% | 23,220 | +54.5% | 0.05% | +24.3% |
| Q3 2021 | $141,000 | -65.7% | 15,031 | -62.6% | 0.04% | -59.8% |
| Q2 2021 | $411,000 | -10.5% | 40,139 | +61.0% | 0.09% | -10.7% |
| Q1 2021 | $459,000 | -50.4% | 24,927 | -7.8% | 0.10% | -54.4% |
| Q4 2020 | $926,000 | +221.5% | 27,027 | +73.5% | 0.23% | +186.1% |
| Q3 2020 | $288,000 | – | 15,575 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,691,623 | $57,938,000 | 8.52% |
| ACUTA CAPITAL PARTNERS, LLC | 393,000 | $13,460,000 | 3.66% |
| Logos Global Management LP | 947,873 | $32,465,000 | 2.78% |
| RTW INVESTMENTS, LP | 2,685,779 | $88,899,000 | 1.49% |
| Avidity Partners Management LP | 1,043,873 | $35,753,000 | 1.16% |
| Perceptive Advisors | 3,114,805 | $106,682,000 | 1.14% |
| Sofinnova Investments, Inc. | 509,168 | $17,439,000 | 1.04% |
| HighVista Strategies LLC | 32,062 | $1,098,000 | 0.70% |
| Rock Springs Capital Management LP | 860,902 | $29,486,000 | 0.62% |
| PFM Health Sciences, LP | 470,227 | $16,105,000 | 0.57% |